Global Structural Heart Disease Treatment Devices Market 2020-2024 | Increasing Structural Heart Diseases to Boost Growth | Technavio

Technavio has announced its latest market research report titled Global Structural Heart Disease Treatment Devices Market 2020-2024 (Graphic: Business Wire)

LONDON--()--Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 2020-2024, progressing at a CAGR of over 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Structural Heart Disease Treatment Devices Market Download free sample report

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Becton, Dickinson and Co., Boston Scientific Corp., Braile Biomédica, CryoLife Inc., Edwards Lifesciences Corp., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova Plc, Medtronic Plc, and MicroPort Scientific Corp. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

The increasing structural heart diseases have been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. https://www.technavio.com/report/report/structural-heart-disease-treatment-devices-market-industry-analysis

Structural Heart Disease Treatment Devices Market 2020-2024: Segmentation

Structural Heart Disease Treatment Devices Market is segmented as below:

■ End-user

■ Hospitals And Clinics

■ ASCs

■ Product

■ Replacement Devices

■ Repair Devices

■ Geographic Landscape

■ Asia

■ Europe

■ North America

■ ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40733

Structural Heart Disease Treatment Devices Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our structural heart disease treatment devices market report covers the following areas:

■ Structural Heart Disease Treatment Devices Market Size

■ Structural Heart Disease Treatment Devices Market Trends

■ Structural Heart Disease Treatment Devices Market Industry Analysis

This study identifies technological innovations as one of the prime reasons driving the structural heart disease treatment devices market growth during the next few years.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Structural Heart Disease Treatment Devices Market 2020-2024 : Key Highlights

■ CAGR of the market during the forecast period 2020-2024

■ Detailed information on factors that will assist structural heart disease treatment devices market growth during the next five years

■ Estimation of the structural heart disease treatment devices market size and its contribution to the parent market

■ Predictions on upcoming trends and changes in consumer behavior

■ The growth of the structural heart disease treatment devices market

■ Analysis of the market’s competitive landscape and detailed information on vendors

■ Comprehensive details of factors that will challenge the growth of structural heart disease treatment devices market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

■ 2.1 Preface

■ 2.2 Preface

■ 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

■ Market ecosystem

■ Market characteristics

■ Value chain analysis

■ Market segmentation analysis

PART 04: MARKET SIZING

■ Market definition

■ Market sizing 2019

■ Market size and forecast 2019-2024

■ Market outlook

PART 05: FIVE FORCES ANALYSIS

■ Bargaining power of buyers

■ Bargaining power of suppliers

■ Threat of new entrants

■ Threat of substitutes

■ Threat of rivalry

■ Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

■ Market segmentation by product

■ Comparison by product

■ Replacement devices - Market size and forecast 2019-2024

■ Repair devices - Market size and forecast 2019-2024

■ Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

■ Geographic segmentation

■ Geographic comparison

■ North America - Market size and forecast 2019-2024

■ Europe - Market size and forecast 2019-2024

■ Asia - Market size and forecast 2019-2024

■ ROW - Market size and forecast 2019-2024

■ Key leading countries

■ Market opportunity

PART 09: MARKET SEGMENTATION BY END USERS

■ Hospitals and clinics

■ ASCs

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

■ Market drivers

■ Market challenges

PART 12: MARKET TRENDS

■ Growing number of strategic alliances

■ Strong clinical pipeline for heart valve devices

■ Technological innovations in structural heart disease treatment

PART 13: VENDOR LANDSCAPE

■ Overview

■ Landscape disruption

■ Competitive scenario

PART 14: VENDOR ANALYSIS

■ Vendors covered

■ Vendor classification

■ Market positioning of vendors

■ Abbott Laboratories

■ Becton, Dickinson and Co.

■ Boston Scientific Corp.

■ Braile Biomédica

■ CryoLife Inc.

■ Edwards Lifesciences Corp.

■ Lepu Medical Technology (Beijing) Co. Ltd.

■ LivaNova Plc

■ Medtronic Plc

■ MicroPort Scientific Corp.

PART 15: APPENDIX

■ Research methodology

■ List of abbreviations

■ Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Release Summary

The Global Structural Heart Disease Treatment Devices Market will grow by USD 5.61 bn during 2020-2024

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/